A fresh outbreak of mpox in Guinea-Bissau—the country's first—has propelled the virus back into the global spotlight, with early data showing children are bearing the brunt of new infections. The development comes as the World Health Organization tallies nearly 190,000 lab-confirmed cases across 145 countries since 2022, raising urgent questions about containment strategies and vaccine equity.
The west African nation of Guinea-Bissau is grappling with its first-ever recorded outbreak of mpox, the viral disease formerly known as monkeypox. According to global health officials, a disproportionate number of cases are affecting children, marking a worrying shift from previous waves. The outbreak is part of a broader resurgence that has seen the virus spread to new geographies after public health emergencies were declared in 2022 and 2024.
Since 2022, almost 190,000 lab-confirmed cases have been reported worldwide across 145 countries—a stark contrast to the pre-2022 era, when outbreaks were typically small and confined to a handful of African nations where the virus was endemic. The current Guinea-Bissau outbreak underscores how the virus continues to expand its geographic footprint, even as global attention has waned.
The World Health Organization has not yet declared a new public health emergency of international concern for this outbreak, but officials are closely monitoring the situation. The heightened risk to children—who were less affected in earlier outbreaks—suggests potential changes in transmission dynamics or population immunity, health experts warn.
In response, international health agencies are calling for ramped-up surveillance, targeted vaccination campaigns, and community engagement to protect vulnerable populations. However, access to vaccines and antiviral treatments remains limited in many affected regions, raising concerns about the world's ability to prevent the outbreak from spiraling into a larger crisis.
Analysis
Why This Matters
- Direct impact on children: The new outbreak's disproportionate effect on children could lead to higher severe illness rates if containment fails, pressuring already strained health systems in West Africa.
- Global spread risk: After appearing in 145 countries since 2022, the virus's continued spread to new countries like Guinea-Bissau shows no sign of abating, threatening international public health.
- Vaccine equity gap: Limited access to vaccines and treatments in low-resource settings undermines global containment efforts and risks prolonging the pandemic phase.
Background
Mpox is a viral zoonosis endemic to parts of Central and West Africa, where it was primarily transmitted through contact with infected animals. Prior to 2022, outbreaks were sporadic and small. That changed dramatically in May 2022 when the virus spread internationally, mostly among men who have sex with men, leading the WHO to declare a Public Health Emergency of International Concern (PHEIC) in July 2022. A second PHEIC was declared in 2024 as a more lethal strain (clade I) emerged in the Democratic Republic of Congo and spread to neighboring countries.
By August 2026, nearly 190,000 lab-confirmed cases had been reported across 145 countries. The virus has since demonstrated an ability to infect diverse populations. The Guinea-Bissau outbreak marks the first time the country has reported community transmission, with children disproportionately affected—a pattern not seen in earlier waves.
Key Perspectives
World Health Organization: Represents the primary global health authority coordinating the response. Its interests lie in containing the outbreak, maintaining surveillance systems, and facilitating access to medical countermeasures—particularly vaccines—for affected countries.
Guinea-Bissau health authorities: Facing a first-time outbreak with limited resources. Their priority is rapid case detection and isolation, public awareness campaigns, and securing international assistance for vaccines and treatments.
Critics/Skeptics: Some public health experts argue that the global response remains reactive rather than preventive. They point to persistent inequities in vaccine distribution and a lack of sustained funding for endemic countries' health systems. Others caution that without stronger community-level engagement, containment efforts may fail to reach marginalized populations.
What to Watch
- Case counts in children: Whether pediatric cases continue to rise and whether severe outcomes (e.g., hospitalization, death) remain elevated compared to adult cases.
- WHO declaration: Whether the organization declares a third PHEIC, which would trigger increased funding, coordination, and travel advisories.
- Vaccine deployment: The speed and scale of vaccine deliveries to Guinea-Bissau and surrounding at-risk countries.
- Cross-border spread: Surveillance data from neighboring nations (Senegal, Guinea, The Gambia) for any signs of exported cases.